WilliamTownerMD

Internal Medicine • Los Angeles, CA

Physician

Join to view full profile

Dr. Towner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Towner's full profile

Already have an account?

Office
4733 W Sunset Blvd
Los Angeles, CA 90027
Phone+1 323-783-4011

Education & Training

Kaiser Permanente Northern California (San Francisco)Residency, Internal Medicine, 1995 - 1997
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Anesthesiology, 1994 - 1995
Kaiser Permanente Northern California (San Francisco)Internship, Internal Medicine, 1993 - 1994
Keck School of Medicine of the University of Southern CaliforniaClass of 1993

Certifications & Licensure

CA State Medical License 1994 - 2026
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Diabetes Recognition Program National Committee for Quality Assurance, 2009-2015
Diabetes Care Recognition Health Care Incentives Improvement Institute

Clinical Trials

Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects Start of enrollment: 2007 Sep 01
Completed
Phase 3
Investigator-Sponsored Protocol - Continued Use of Ibalizumab Start of enrollment: 2009 Nov 01
Completed
Phase 2
Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus Start of enrollment: 2011 Dec 01
Completed
Phase 3
Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives) Start of enrollment: 2012 May 01
Completed
Phase 3
Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV Start of enrollment: 2015 Aug 01
Completed
Phase 3
Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1 Start of enrollment: 2016 Mar 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

10 citations
Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016.
Jennifer O Lam, Catherine Lee, Paola Gilsanz, Craig E. Hou, Wendy A. Leyden
AIDS. 2021-11-24
6 citations
Referral Linkage to Preexposure Prophylaxis Care and Persistence on Preexposure Prophylaxis in an Integrated Health Care System.
Katia Bruxvoort, Christina Schumacher, William J. Towner, Joyce Jones, Richard Contreras
Journal of Acquired Immune Deficiency Syndromes. 2021-07-01
4 citations
Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals
Sarah-Jane Anderson, Miranda Murray, David Cella, Robert M. Grossberg, Debbie Hagins
The Patient. 2021-06-28

Journal Articles

Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults with and Without HIV Infection, 2000-2016
William J Towner, Michael A Horberg, JAMA Network Open

Authored Content

Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults with and Without HIV Infection, 2000-2016June 2020

Press Mentions

C.D.C. Is Anticipated to Suggest Vaccines for Younger YoungstersJune 19th, 2022
C.D.C. Panel Meets to Vote on Covid Vaccines for Children Under 5: Live UpdatesJune 18th, 2022
The C.D.C. Is Expected to Recommend Vaccinations of Young ChildrenJune 18th, 2022
Join now to see all

Professional Memberships

Infectious Disease Society of America - IDSA
Member
American College of Physicians - ACP
Fellow